Product
Industries
Pharma
Biotech
Finance
CRO
Communications
Insights
Company
Log in
Book Demo
Pre-news from
Applied XL
Subscribe to receive pre-news
Thank you! We have added you to our list.
Oops! Something went wrong while submitting the form.
April 2023
How Feldan Therapeutics uses “kill sheets” to make data driven decisions about clinical development
Case Study
March 2023
Early signals in Aileron Therapeutic's ALRN-6924 program hinted at struggles for efficacy over a year before negative results
Case Study
February 2023
Did irregular shifts in clinical trial progression at Flagship’s Repertoire foreshadow the termination of its immuno-oncology program?
Case Study
November 2022
Could warning signs in Summit Therapeutics’ clinical trial activity have hinted at bad results months before they were announced?
Case Study
November 2022
Could early red flags in Takeda’s blood cancer program have signaled the failure of their next potential blockbuster?
Case Study
August 2022
How hidden signals in public data unveiled turmoil in one of the world’s most valuable biotech startups
Case Study
August 2022
Did hidden signals in data anticipate bad news for TG Therapeutics' clinical trial for chronic lymphocytic leukemia?
Case Study
March 2022
AppliedXL partners with STAT to launch a new clinical trials monitoring platform powered by artificial intelligence
Life Sciences
January 2022
Why we are building a real-time Information company powered by editorial algorithms
Life Sciences